First-pass extracted concept

neurodegenerative diseases

Candidate: concept label2 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

As optogenetics precisely targets and modulates neuronal activity, it holds the potential for significant breakthroughs in understanding and potentially altering the course of neurodegenerative diseases, characterized by selective neuronal loss leading to functional deficits within the nervous system.

Evidence 1Source 1DOI PubMedprovenance

The review title explicitly states implications for neurodegenerative diseases.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2024MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Source 2review2018Neurobiology of DiseaseDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Linked Claims

Claim 1application potentialsupports2024Source 1DOI PubMed

Optogenetics has potential to advance understanding of and potentially alter the course of neurodegenerative diseases.

Claim 2field progresssupports2024Source 1DOI PubMed

Integration of optogenetics into neurodegenerative disease research has significantly advanced the field and opened innovative treatment strategies.

Claim 3translational statussupports2024Source 1DOI PubMed

Clinical application of optogenetics in neurodegenerative disease is still nascent but appears promising.

Claim 4review scope summarysupports2018Source 2DOI PubMed

The review centers on selective autophagy receptors and neurodegeneration-linked receptors including SQSTM1/p62 and OPTN.